Ledger.Open graph →
SEC Form D · filed June 25, 2024

Cerecin Inc

Offering
$7.0M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Samuel T. Henderson · Denver, COExecKikab T. Kim · Denver, CODirectorNicholas C. Stacey · Denver, COExec · DirectorJerris T. Knaisch · Denver, COExecWolfgang T. Reichenberger · Denver, CODirectorClaude T. Nash · Denver, CODirectorScott M. Verlander · Jacksonville, FLExec · DirectorOluwaseun Oyinsan · Millbury, MAExecBoaz Gorfung · Kadima, L3ExecAdam Guggenheim · Palos Verdes Estates, CADirectorDaniel Pickering · Houston, TXDirectorWalker Moody · Houston, TXDirectorRahul T. Rajashekar · Denver, CODirectorDilpreet T. Singh · Denver, COExecHans-Juergen T. Woerle · Denver, CODirectorNayel M. Nassar · Denver, CODirectorAurora R. Cassirer · Elmsford, NYDirectorMaria R. Schroeder · Elmsford, NYExecPeter Kim · Irvine, CAExecRishabh Agarwal · New Haven, CTDirectorMichael Schumacher · Carlsbad, CAExec · DirectorRahul T. Rajashekar · Denver, CODirectorDilpreet T. Singh · Denver, COExecHans-Juergen T. Woerle · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗